<?xml version="1.0" encoding="UTF-8"?>
<p>In Korea, Dong-A ST (Seoul, Korea) developed a recombinant human G-CSF, Leucostim
 <sup>Â®</sup>. It is synthesized by recombinant protein expression in 
 <italic>E. coli</italic> and is activated by a refolding process. In the biochemical testing, it has been shown that the biological efficacy was equivalent to the endogenous G-CSF. The formulation is identical to the original product except addition of D-mannitol as an excipient.
</p>
